| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d3020ad67c717f34d32e1448c74281 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa0a175b3bf8739af9c0c9d865a07aca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70c4f6a7a7e01b5c5358d1564c7d4a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c09df4dea14c42c38218af6fe2de352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab5bdb807181f4817867dcdf55a7bde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38440560b97613c13adc9c6228546c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1de435e0b0275dd8230a1110f58e2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27295ac61f4e212adc74fac389848aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b1172ef12182b886796f92d1d6b83aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a71f66627000c2121fe642f78a766212 |
| publicationDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017232083-B2 |
| titleOfInvention |
Amino-LNA, thio-LNA and alpha-L-oxy-LN |
| abstract |
Abstract A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides. |
| priorityDate |
2002-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |